½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1363801

¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : Á¦Ç°º°, ÀåÄ¡º°, ¿ëµµº°, Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Wearable Heart Monitoring Devices Market Size Study & Forecast, by Product, By Devices, By Application, and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅÍ µð¹ÙÀ̽º´Â ½ÉÀå È°µ¿À» ÃßÀûÇÏ°í Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϵµ·Ï ¼³°èµÈ ÈÞ´ë¿ë ÀüÀÚ ÀåÄ¡ÀÔ´Ï´Ù.

ÀÌ·¯ÇÑ ÀåÄ¡´Â ÀϹÝÀûÀ¸·Î ¼Õ¸ñÀ̳ª °¡½¿¿¡ Âø¿ëÇÏ¿© ½É¹Ú¼ö, ½ÉÀå ¹Úµ¿¼ö ¹× ±âŸ °ü·Ã µ¥ÀÌÅ͸¦ ¸ð´ÏÅ͸µÇÏ°í ±â·ÏÇÕ´Ï´Ù. ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅÍ µð¹ÙÀ̽ºÀÇ ÁÖ¿ä ¸ñÀûÀº ½ÉÀå È°µ¿ÀÇ ºÒ±ÔÄ¢¼º°ú ÀÌ»óÀ» ½Äº°ÇÏ°í »ç¿ëÀÚ¿¡°Ô ½ÉÀå °Ç°­¿¡ ´ëÇÑ ½Ç½Ã°£ Á¤º¸¸¦ Á¦°øÇÏ´Â °ÍÀÔ´Ï´Ù. °³ÀÎ °Ç°­ ¹× ÇÇÆ®´Ï½º¿¡ ´ëÇÑ °ü½É Áõ°¡, ¿þ¾î·¯ºí ±â¹Ý ½ÉÀå ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, µðÁöÅÐ °Ç°­ »ýÅ°è¿ÍÀÇ ±Þ¼ÓÇÑ ÅëÇÕ, °í·ÉÈ­ Àα¸ Áõ°¡ ¹× ¸¸¼º Áúȯ °ü¸®¿Í °°Àº ¿äÀÎÀÌ ¼¼°è ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ°í ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼¼°è ½ÃÀå¿¡¼­ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º¿¡ ´ëÇÑ ¼ö¿ä¿Í Á÷Á¢ÀûÀ¸·Î ¿¬°üµÇ¾î ÀÖ½À´Ï´Ù. ½ÉÀ庴, ³úÁ¹Áß, ºÎÁ¤¸Æ°ú °°Àº ½ÉÇ÷°ü ÁúȯÀº ¼¼°èÀûÀ¸·Î ½É°¢ÇÑ °Ç°­ ¹®Á¦ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ½ÉÀå ÀÌ»óÀ» °¨ÁöÇÏ°í °ü¸®Çϱâ À§ÇØ Áö¼ÓÀûÀÎ ½ÉÀå ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ Áõ°¡ÇÏ¿© ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ°í ÀÖÀ¸¸ç, 2022³â 10¿ù CDC º¸°í¼­¿¡ µû¸£¸é °ü»ó µ¿¸Æ ½ÉÀå ÁúȯÀº °¡Àå ÈçÇÑ ½ÉÀå ÁúȯÀ¸·Î ±â·ÏµÇ¾ú½À´Ï´Ù. À¸·Î ±â·ÏµÇ¾î ÀÖÀ¸¸ç, 20¼¼ ÀÌ»ó ¼ºÀÎÀÇ ¾à 2,010¸¸ ¸í(¾à 7.2%)ÀÌ °ü»óµ¿¸ÆÁúȯÀ» ¾Î°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹½ÉÀåÇùȸ¿¡ µû¸£¸é, ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚ ¼ö´Â ¼¼°èÀûÀ¸·Î ¸Å³â ¾à 1,730¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ, 2030³â±îÁö ½ÉÇ÷°ü Áúȯ ȯÀÚ´Â ¾à 2,360¸¸ ¸í Áõ°¡ÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ÀÌó·³ °ü»óµ¿¸ÆÁúȯÀÇ ³ôÀº ºÎ´ãÀº ÃßÁ¤ ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ Áõ°¡ Ãß¼¼¿Í ¿þ¾î·¯ºí ±â±âÀÇ ±â¼ú ¹ßÀüÀº ¿¹Ãø ±â°£ µ¿¾È ´Ù¾çÇÑ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª ¿þ¾î·¯ºí ±â±â¿¡ ´ëÇÑ ÇÁ¶óÀ̹ö½Ã ¹× º¸¾È¿¡ ´ëÇÑ ¿ì·Á Áõ°¡¿Í ¾ö°ÝÇÑ ±ÔÄ¢ ¹× ±ÔÁ¦ Á¤Ã¥ÀÇ ºÎ°ú´Â 2023-2030³âÀÇ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ µµÀüÀÌ µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

¼¼°è ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µîÀÔ´Ï´Ù. ºÏ¹Ì´Â °³ÀÎÀÇ °Ç°­°ú ÇÇÆ®´Ï½º¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁø µ¥´Ù ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç¿Í ÀÌ Áö¿ªÀÇ Àü·«Àû À̴ϼÅƼºê·Î ÀÎÇØ 2022³â ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 3¿ù ¹ÙÀÌ¿ÀÆ®¸®½ÃƼ(Biotricity Inc.)´Â FDAÀÇ ½ÂÀÎÀ» ¹ÞÀº ¹«¼± ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽ºÀÎ ¹ÙÀÌ¿ÀÆ®·¹½ºÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÇÑÆí, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGR·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °í·É Àα¸ Áõ°¡, ¿ìÈ£ÀûÀÎ ±ÔÁ¦ ȯ°æ, ƯÈ÷ ½ÅÈï °æÁ¦±¹¿¡¼­ ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ Áö¿ª Àüü ½ÃÀå ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆľÇÇÏ°í ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû/¾çÀû Ãø¸éÀ» Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï ±¸µµ¿Í Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • ¾÷°è ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó³â
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ¿ªÇÐ

  • ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
    • ½ÃÀå ±âȸ

Á¦4Àå ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ¼¼°è ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's Five Forces ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ¹ÙÀ̾îÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's Five Forces ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19ÀÇ ¿µÇ⠺м®
  • Æı«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °ßÇØ
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð ¹× Á¦¾È

Á¦5Àå ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : Á¦Ç°º°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø2020-2030³â
  • ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Àü±â ÆÞ½º ±â¹Ý Á¦Ç°
    • ±¤ÇÐ ±â¼ú ±â¹Ý Á¦Ç°

Á¦6Àå ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : µð¹ÙÀ̽ºº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : µð¹ÙÀ̽ºº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : µð¹ÙÀ̽ºº° ÃßÁ¤¡¤¿¹Ãø2020-2030³â
  • ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • Áø´Ü¡¤¸ð´ÏÅ͸µ ±â±â
    • Ä¡·á¿ë µð¹ÙÀ̽º

Á¦7Àå ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ¿ëµµº°, ½ÇÀû-°¡´É¼º ºÐ¼®
  • ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø2020-2030³â
  • ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ½ºÆ÷Ã÷£¦ÇÇÆ®´Ï½º
    • ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ
    • Ȩ ÇコÄɾî

Á¦8Àå ¼¼°èÀÇ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ Àåºñ ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • Á¦Ç° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • µð¹ÙÀ̽ºº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´ ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ µð¹ÙÀ̽º ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¿þ¾î·¯ºí ½ÉÀå ¸ð´ÏÅ͸µ ±â±â ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Medtronic plc
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • BioTelemetry, Inc.
    • Boston Scientific
    • ZOLL Medical Corporation
    • Heartbit Holdings Plc.
    • iRhythm Technologies, Inc.
    • ACS Diagnostics, Inc.
    • General Electric Company(GE Healthcare, Inc.)
    • Hemodynamics Company LLC
    • Sonova Holding AG

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
LSH 23.10.25

Wearable heart monitoring devices are portable electronic devices that are designed to track and continually monitor the activities of the heart. These devices are normally worn on the body, usually on the wrist or chest to monitor and record heart rate, heart rhythm, and other pertinent data. The primary objectives of wearable heart monitoring devices are to identify any irregularities or abnormalities in heart activity and provide users with real-time information about their heart health. Factors such as growing emphasis on personal health and fitness, rising awareness of wearables-based cardiac monitoring, and rapid integration with digital health ecosystems, coupled with the increasing aging population and chronic disease management are driving the market growth worldwide.

Additionally, the increasing prevalence of cardiovascular diseases is directly associated with the demand for wearable heart monitoring devices in the global market. Cardiovascular diseases, such as heart disease, stroke, and arrhythmias, are significant global health concerns. The rising incidence of these conditions has created a greater need for continuous heart monitoring to detect and manage cardiac abnormalities, leading to increased demand for wearable heart monitoring devices. As per the CDC report of October 2022, coronary heart disease is recorded as the most common form of heart disease, and nearly 20.1 million adults aged 20 and over have coronary artery disease (approximately 7.2%). Moreover, according to the American Heart Association, cardiovascular diseases are projected around 17.3 million deaths globally every year. Also, it is estimated that cardiovascular disease cases are likely to rise by about 23.6 million by 2030. Thus, the high burden of coronary artery disease is driving the growth of the market during the estimated period. Furthermore, the growing trend of remote patient monitoring, as well as the increasing technological advancements in wearable devices present various lucrative opportunities over the forecasting years. However, the rising privacy and security concerns regarding wearable devices and the imposition of stringent rules & regulatory policies are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Wearable Heart Monitoring Devices Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising focus on personal health and fitness, along with the presence of major market players and their strategic initiatives in the region. For instance, in March 2022, Biotricity Inc. announce the launch of Biotres- a wireless wearable cardiac monitoring device, which is approved by the FDA. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rising geriatric population, the presence of a supportive regulatory environment, as well as increasing adoption of remote patient monitoring especially in developing economies are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Medtronic plc
  • BioTelemetry, Inc.
  • Boston Scientific
  • ZOLL Medical Corporation
  • Heartbit Holdings Plc.
  • iRhythm Technologies, Inc.
  • ACS Diagnostics, Inc.
  • General Electric Company
  • Hemodynamics Company LLC
  • Sonova Holding AG .

Recent Developments in the Market:

  • In 2021, RhythMedix unveiled the introduction of the RhythmStar- a wearable cardiac monitoring device for arrhythmia detection. The new RhythmStar is a modestly worn gadget that enables long-term remote monitoring without the need for a phone or other communication tools. With the use of the technology, the company's team of licensed experts in the US swiftly examine ECGs and identify cardiac abnormalities, notifying physicians when a potentially serious arrhythmia is found.

Global Wearable Heart Monitoring Devices Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product, Devices, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product:

  • Electric Pulse-based Product
  • Optical Technology-based Product

By Devices:

  • Diagnostic & Monitoring Devices
  • Therapeutic Devices

By Application:

  • Sports & Fitness
  • Remote Patient Monitoring
  • Home Healthcare

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Wearable Heart Monitoring Devices Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Wearable Heart Monitoring Devices Market, by Product, 2020-2030 (USD Billion)
    • 1.2.3. Wearable Heart Monitoring Devices Market, by Devices, 2020-2030 (USD Billion)
    • 1.2.4. Wearable Heart Monitoring Devices Market, by Application, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Wearable Heart Monitoring Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Wearable Heart Monitoring Devices Market Dynamics

  • 3.1. Wearable Heart Monitoring Devices Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing prevalence of cardiovascular diseases globally
      • 3.1.1.2. Growing emphasis on personal health and fitness
    • 3.1.2. Market Challenges
      • 3.1.2.1. Rising privacy and security concerns regarding wearable devices
      • 3.1.2.2. Imposition of stringent rules & regulatory policies
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing trend of remote patient monitoring
      • 3.1.3.2. Increasing technological advancements in wearable devices

Chapter 4. Global Wearable Heart Monitoring Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Wearable Heart Monitoring Devices Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Wearable Heart Monitoring Devices Market by Product, Performance - Potential Analysis
  • 5.3. Global Wearable Heart Monitoring Devices Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
  • 5.4. Wearable Heart Monitoring Devices Market, Sub Segment Analysis
    • 5.4.1. Electric Pulse-based Product
    • 5.4.2. Optical Technology-based Product

Chapter 6. Global Wearable Heart Monitoring Devices Market, by Devices

  • 6.1. Market Snapshot
  • 6.2. Global Wearable Heart Monitoring Devices Market by Devices, Performance - Potential Analysis
  • 6.3. Global Wearable Heart Monitoring Devices Market Estimates & Forecasts by Devices 2020-2030 (USD Billion)
  • 6.4. Wearable Heart Monitoring Devices Market, Sub Segment Analysis
    • 6.4.1. Diagnostic & Monitoring Devices
    • 6.4.2. Therapeutic Devices

Chapter 7. Global Wearable Heart Monitoring Devices Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Wearable Heart Monitoring Devices Market by Application, Performance - Potential Analysis
  • 7.3. Global Wearable Heart Monitoring Devices Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 7.4. Wearable Heart Monitoring Devices Market, Sub Segment Analysis
    • 7.4.1. Sports & Fitness
    • 7.4.2. Remote Patient Monitoring
    • 7.4.3. Home Healthcare

Chapter 8. Global Wearable Heart Monitoring Devices Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Wearable Heart Monitoring Devices Market, Regional Market Snapshot
  • 8.4. North America Wearable Heart Monitoring Devices Market
    • 8.4.1. U.S. Wearable Heart Monitoring Devices Market
      • 8.4.1.1. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Devices breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Wearable Heart Monitoring Devices Market
  • 8.5. Europe Wearable Heart Monitoring Devices Market Snapshot
    • 8.5.1. U.K. Wearable Heart Monitoring Devices Market
    • 8.5.2. Germany Wearable Heart Monitoring Devices Market
    • 8.5.3. France Wearable Heart Monitoring Devices Market
    • 8.5.4. Spain Wearable Heart Monitoring Devices Market
    • 8.5.5. Italy Wearable Heart Monitoring Devices Market
    • 8.5.6. Rest of Europe Wearable Heart Monitoring Devices Market
  • 8.6. Asia-Pacific Wearable Heart Monitoring Devices Market Snapshot
    • 8.6.1. China Wearable Heart Monitoring Devices Market
    • 8.6.2. India Wearable Heart Monitoring Devices Market
    • 8.6.3. Japan Wearable Heart Monitoring Devices Market
    • 8.6.4. Australia Wearable Heart Monitoring Devices Market
    • 8.6.5. South Korea Wearable Heart Monitoring Devices Market
    • 8.6.6. Rest of Asia Pacific Wearable Heart Monitoring Devices Market
  • 8.7. Latin America Wearable Heart Monitoring Devices Market Snapshot
    • 8.7.1. Brazil Wearable Heart Monitoring Devices Market
    • 8.7.2. Mexico Wearable Heart Monitoring Devices Market
  • 8.8. Middle East & Africa Wearable Heart Monitoring Devices Market
    • 8.8.1. Saudi Arabia Wearable Heart Monitoring Devices Market
    • 8.8.2. South Africa Wearable Heart Monitoring Devices Market
    • 8.8.3. Rest of Middle East & Africa Wearable Heart Monitoring Devices Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Medtronic plc
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. BioTelemetry, Inc.
    • 9.3.3. Boston Scientific
    • 9.3.4. ZOLL Medical Corporation
    • 9.3.5. Heartbit Holdings Plc.
    • 9.3.6. iRhythm Technologies, Inc.
    • 9.3.7. ACS Diagnostics, Inc.
    • 9.3.8. General Electric Company (GE Healthcare, Inc.)
    • 9.3.9. Hemodynamics Company LLC
    • 9.3.10. Sonova Holding AG

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦